Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Laparoscopic Myomectomy Morcellation Cancer Risks May Be Much Lower Than Hysterectomy: Study October 9, 2015 Irvin Jackson Add Your Comments Amid continuing concerns about the increased risk of spreading undiagnosed cancer with morcellation used during laparoscopic hysterectomy and myomectomy procedures, new research suggests that individuals who are only having uterine fibroids removed, keeping the uterus mostly intact, may face less of a risk during the minimally invasive procedure. Morcellators are medical devices used during laparoscopic surgery to allow the doctors to cut up the uterus or fibroids through a small incision in the abdomen, avoiding the risks associated with traditional or open procedures. The devices have become increasingly popular in recent years during complete hysterectomies and myomectomies, where only the uterine fibroids are removed. Over the past year, the devices have been largely abandoned within the medical community after it was discovered that many women undergoing a laparoscopic hysterctomy or myomectomy for symptomatic uterine fibroids have undiagnosed cancers hidden within the uterus. For these women, morcellation may rapidly upstage aggressive cancers like leiomyoscarcoma, endometrial stromal sarcoma or other uterine sarcoma. Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a study published this month in the American Journal of Obstetrics and Gynecology (PDF), Italian researchers indicate that the rate of unsuspected cancers found within women who undergo a myomectomy is much less than that found among women who underwent a hysterectomy. Researchers suggest the different morcellation risks may be because women who have a myomectomy, which often allows a woman to still bear children, are typically younger than those having a hysterectomy Prior estimates released by the FDA suggest that as many as one out of every 350 women undergoing surgery may have unsuspected sarcoma, leading most experts to avoid using morcellators during any myomectomies or hysterectomies. In this latest study, researchers suggest that those estimates are more accurate for women undergoing a hysterectomy than those who receive a myomectomy. Researchers from Milan looked at a database of laparoscopic myomectomies from January 1999 to December 2013, involving 2,356 women. All of the cases involved fibroids removed with power morcellators. They found one case that resulted in advanced stage leiomyosarcoma, and another involving a smooth muscle tumor of uncertain malignant potential (STUMP). The woman with leiomyosarcoma died four months after her procedure. The STUMP case never developed into cancer and was cancer-free two years after her surgery. “In our large myomectomy series, the risk of unexpected leiomyosarcoma was less than 1/2000,” the researchers noted. “Including the STUMP case, the proportion of unexpected tumors was below 1/1000, substantially lower than that indicated by the FDA. However, the FDA estimate was based mainly on hysterectomy series, in which the risk of occult leiomyosarcoma should be higher because women are generally older than those undergoing myomectomy.” The study suggests that the risk of undiagnosed leiomyosarcoma in younger women, who opt for a myomectomy because they can often still have children later in life, is “exceedingly” low. Morcellation Cancer Lawsuits There are currently several dozen power morcellator cancer lawsuits pending throughout the federal court system against manufacturers of the devices, alleging that inadequate warnings were provided about the cancer risks for women undergoing a laparoscopic myomectomy or hysterectomy. As lawyers continue to review and file morcellator cases for women diagnosed with the spread of uterine cancer following a hysterectomy or uterine fibroid removal, it is ultimately expected that several hundred lawsuits will be filed nationwide. In June, a group of plaintiffs filed a motion to centralize the power morcellator litigation before one judge in the federal court system, which is designed to reduce duplicative discovery into common issues in the cases, avoid conflicting rulings from different courts and the serve the convenience of the witnesses, parties and the judicial system. Johnson & Johnson’s Ethicon subsidiary, Karl Storz, Richard Wolf Medical and other manufacturers of the controversial devices have opposed the creation of a morcellator MDL, arguing that there are too many different manufacturers and types of devices involved in the cases to justify centralization, and that the lawsuits will be dominated by the individual facts of each case. The U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments last week on whether to consolidate the cases. A ruling is expected soon. Tags: Cancer, Hysterectomy, Leiomyosarcoma, Morcellation, Myomectomy, Uterine Cancer, Uterine Fibroid Removal Image Credit: | More Morcellation Lawsuit Stories FDA Issues New Guidelines, Safety Communication On Use Of Power Morcellators February 26, 2020 Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019 CDC Weighs New Guidelines For Gynecologists For Detecting Uterine Cancer May 11, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: today) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025) 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: today) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)